(TGTX) TG Therapeutics - Performance 93.2% in 12m
TGTX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
33.20%
#13 in Peer-Group
Rel. Strength
93.11%
#530 in Stock-Universe
Total Return 12m
93.16%
#16 in Peer-Group
Total Return 5y
79.56%
#17 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 149 |
| P/E Forward | 26.3 |
| High / Low | USD |
|---|---|
| 52 Week High | 45.51 USD |
| 52 Week Low | 17.21 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 44.46 |
| Buy/Sell Signal +-5 | 0.75 |
| Support / Resistance | Levels |
|---|---|
| Support | 34.7, 33.6, 30.6, 24.8, 23.4 |
| Resistance | 39.2, 37.3 |
12m Total Return: TGTX (93.2%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: TGTX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for TGTX
| Total Return (including Dividends) | TGTX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -0.85% | 3.36% | 5.25% |
| 3 Months | -1.69% | 15.73% | 24.13% |
| 12 Months | 93.16% | -7.02% | 14.15% |
| 5 Years | 79.56% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | TGTX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -49.1% | 4.4% | 81% |
| 3 Months | -19.8% | 78.8% | 96.9% |
| 12 Months | 88.8% | -85.8% | 44.9% |
| 5 Years | -8.8% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th49.50 | -4.07% | -5.79% |
| 3 Month | %th28.00 | -15.05% | -20.80% |
| 12 Month | %th92.00 | 107.76% | 69.21% |
| 5 Years | %th93.00 | 136.92% | -15.23% |
FAQs
Does TG Therapeutics (TGTX) outperform the market?
Yes,
over the last 12 months TGTX made 93.16%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months TGTX made -1.69%, while XBI made 15.73%.
Performance Comparison TGTX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
TGTX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -1.7% | -6.1% | 25.5% | 79% |
| US NASDAQ 100 | QQQ | -1.5% | -6.2% | 24.8% | 80% |
| German DAX 40 | DAX | 0.4% | 0.6% | 13.3% | 64% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -1.5% | -4.1% | 22.1% | 73% |
| Hongkong Hang Seng | HSI | -1.3% | -6.9% | 6% | 55% |
| India NIFTY 50 | INDA | 0.1% | -4.3% | 25.2% | 94% |
| Brasil Bovespa | EWZ | -4.2% | -9.7% | 0.4% | 83% |
TGTX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -0.3% | -6.8% | 21.4% | 69% |
| Consumer Discretionary | XLY | -1.2% | -4% | 33.1% | 75% |
| Consumer Staples | XLP | -2% | -1.5% | 23.8% | 84% |
| Energy | XLE | -2% | -7.9% | 29.6% | 93% |
| Financial | XLF | -2.4% | -5.9% | 20.6% | 63% |
| Health Care | XLV | -1.2% | -3% | 32.8% | 98% |
| Industrial | XLI | -1.8% | -5.1% | 17.6% | 68% |
| Materials | XLB | -4% | -5.1% | 21% | 87% |
| Real Estate | XLRE | -1.7% | -1.8% | 25.8% | 80% |
| Technology | XLK | -2.5% | -9.5% | 23.2% | 82% |
| Utilities | XLU | -0.6% | -2.6% | 22.3% | 70% |
| Aerospace & Defense | XAR | 0.4% | -7.9% | 6.9% | 44% |
| Biotech | XBI | -2.7% | -4.2% | 38.7% | 100% |
| Homebuilder | XHB | -4.2% | -7.9% | 32.7% | 88% |
| Retail | XRT | -4.2% | -5.8% | 29.8% | 82% |
TGTX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -2.6% | -9.29% | 33.9% | 101% |
| Natural Gas | UNG | 7.8% | 9% | 42.3% | 95% |
| Gold | GLD | -2% | 0.4% | 4.8% | 54% |
| Silver | SLV | -2.7% | -7.8% | 8.1% | 76% |
| Copper | CPER | -0.8% | -5.4% | 8.4% | 82% |
TGTX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 0.1% | -1.9% | 28.9% | 95% |
| iShares High Yield Corp. Bond | HYG | -0.5% | -2.5% | 26.6% | 83% |